(FVC) |
| 0 (0%) 04-14 16:56 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 43.17 |
| Resistance 1: | 36.96 |
| Pivot price: | 35.52 |
| Support 1: | 34.88 |
| Support 2: | 33.59 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 13 Apr 2026
Baseball: Clements, McHenry shut out Crystal Lake South in FVC - Daily Herald
Mon, 13 Apr 2026
Photos: McHenry vs. Crystal Lake South FVC baseball - Shaw Local
Fri, 10 Apr 2026
Ian Boland attacks, McHenry manufactures runs in FVC win against Crystal Lake South - Shaw Local
Fri, 10 Apr 2026
(FVC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Mon, 30 Mar 2026
United's nebulised Tyvaso formulation comes up trumps again in pivotal IPF study - FirstWord Pharma
Mon, 30 Mar 2026
United Therapeutics: TETON-1 Tyvaso trial met primary endpoint, FVC benefit of 130.1 mL - TradingView — Track All Markets
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
